Label Image (Lbl500906456)
Trulicity Injection, Solution
Product Images NDC 50090-6456
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Trulicity (NDC 50090-6456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Logo)
Qr Code (Qr V1)
Figure (Trulicity Ifu 0point75 Injection Sites Back V1)
Figure (Trulicity Ifu 0point75 Injection Sites Front V1)
Figure (Trulicity Ifu 1point5 Injection Sites Back V1)
Figure (Trulicity Ifu 1point5 Injection Sites Front V1)
Figure (Trulicity Ifu 3mg Injection Sites V1)
Figure (Trulicity Ifu 4point5mg Injection Sites V1)
Figure (Trulicity Ifu Check V1)
Exclamation (Trulicity Ifu Exclamation V1)
Figure (Trulicity Ifu Expiration Location V2)
Figure (Trulicity Ifu Inspect V1)
Locked (Trulicity Ifu Locked V1)
Figure (Trulicity Ifu Prepare V1)
Figure (Trulicity Ifu Remove V1)
Figure (Trulicity Ifu Sup 0point75 F2 V3)
Figure (Trulicity Ifu Sup 0point75 F3 V3)
Figure (Trulicity Ifu Sup 0point75 F4 V3)
Figure (Trulicity Ifu Sup 0point75 F5 V3)
Figure (Trulicity Ifu Sup 0point75 Pen Parts V3)
This is a description of a medical device used for injections. The device consists of a top section and a bottom section separated by a clear base. The top section includes an injection button, a lock ring, an indicator, and a lock/unlock mechanism. The bottom section includes a needle end and a base cap. The device appears to be adjustable and customizable to suit the needs of different patients and injection types.*
Figure (Trulicity Ifu Sup 0point75 Pen V3)
Figure (Trulicity Ifu Sup 1point5 F2 V3)
Figure (Trulicity Ifu Sup 1point5 F3 V3)
Figure (Trulicity Ifu Sup 1point5 F4 V3)
Figure (Trulicity Ifu Sup 1point5 F5 V3)
Figure (Trulicity Ifu Sup 1point5 Pen Parts V3)
This text appears to be a diagram or image showing the components of a medical injection device. It includes labels for a "Top", "Lock Ring", "Indicator", "Medicine", "Bottom/Clear Base", "Needle", and "End Cap". It is not possible to provide more detailed information without additional context or visual reference.*
Figure (Trulicity Ifu Sup 1point5 Pen V3)
Figure (Trulicity Ifu Sup 3mg F2 V1)
Figure (Trulicity Ifu Sup 3mg F3 V1)
Figure (Trulicity Ifu Sup 3mg F4 V1)
This text appears to be a short message or instruction about injection and the visibility of a gray plunger to confirm completion. It is unclear what type of injection is being referred to or any other context surrounding the message.*
Figure (Trulicity Ifu Sup 3mg F5 V1)
Figure (Trulicity Ifu Sup 3mg Pen Parts V1)
Figure (Trulicity Ifu Sup 3mg Pen V1)
Figure (Trulicity Ifu Sup 4point5 F2 V1)
Figure (Trulicity Ifu Sup 4point5 F3 V1)
Figure (Trulicity Ifu Sup 4point5 F4 V1)
This text seems to be an instruction for an injection. It mentions the "gray plunger", which is an indicator to show that the injection is complete. However, there is not enough context to determine what type of injection or where it should be administered.*
Figure (Trulicity Ifu Sup 4point5 F5 V1)
Figure (Trulicity Ifu Sup 4point5 Pen Parts V1)
This is a not-available description because the given text seems to be a list of words or phrases that do not convey any coherent meaning.*
Figure (Trulicity Ifu Sup 4point5 Pen V1)
Figure (Trulicity Ifu Unfold V1)
Unlocked (Trulicity Ifu Unlock V1)
Figure 1 (Trulicity Pi F1 V2)
The text seems to be a list of factors or variables related to a medical condition, possibly related to the effects of Intrinsic Factor. It includes information such as weight, age, gender, ethnicity, renal and hepatic impairments, and different levels of severity. There are also terms related to statistics or pharmacokinetics listed at the end.*
Figure 2 (Trulicity Pi F2 V2)
Figure 3 (Trulicity Pi F3 V3)
Figure 4 (Trulicity Pi F4 V3)
This is a chart showing mean HbA1c (%) levels ranging from 85 to 65 and Trulicity dosage variants of 1.5mg, 3mg, and 4.5mg. The chart also includes a weeks post-randomization timeline from week 12 to week 36.*
Figure 5 (Trulicity Pi F5 V2)
This is a clinical trial report showing the LS mean HbA1 (%) values at 26 weeks post-randomization for four different treatments including Trulicity (15mg and 0.75mg), Exenaide, and Piacabo. The HbA1 (%) values ranged from 8.0 to 6.0 across the treatments.*
Figure 6 (Trulicity Pi F6 V2)
This is a statistical report on the effectiveness of the drug Dulaglutide in reducing the number of events in patients as compared to a placebo. The data shows that patients on Dulaglutide had a lower incidence of events with a hazard ratio (HR) of 0.88 and a confidence interval (CI) of 95%. The time in years from randomization is also presented as 6 years.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
